feed,title,long_url,short_url
Benzinga,Sarepta Therapeutics' Shares Plummet Following FDA's Clinical Hold On MOMENTUM Study,https://benzinga.com/general/biotech/22/06/27836301/sarepta-therapeutics-shares-plummet-following-fdas-clinical-hold-on-momentum-study,https://bit.ly/3tWO0Eu
